Want to join the conversation?
$ABBV 2Q15 Call: Earlier this year, we entered into collaboration with C2N Diagnostics to develop and commercialize a portfolio of anti-tau antibodies. We recently received an Orphan Drug Designation for HUMIRA and initiated a phase I program. We are on track to start clinical development with C2N in Alzheimer’s disease in 2016.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.